Pharmacotherapy in cancer patients with HIV/AIDS

J. H. Beumer, R. Venkataramanan, M. A. Rudek

Research output: Contribution to journalArticlepeer-review


Antiretroviral therapy (ART) has significantly reduced morbidity and increased life expectancy of individuals infected with human immunodeficiency virus (HIV). Consequently, non-acquired immunodeficiency syndrome (AIDS)-defining malignancies are increasing in frequency, which necessitates the concurrent use of antineoplastics and ART. Although drug interactions are a major concern when combining these agents, there is currently limited guidance on dose adjustments required to maintain safe and efficacious drug exposure.

Original languageEnglish (US)
Pages (from-to)370-372
Number of pages3
JournalClinical pharmacology and therapeutics
Issue number4
StatePublished - Apr 2014

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)


Dive into the research topics of 'Pharmacotherapy in cancer patients with HIV/AIDS'. Together they form a unique fingerprint.

Cite this